30 janv. 2018 - FDA held a public hearing, “Opioid Policy Steering Committee: Prescribing Intervention- Exploring a Strategy for Implementation” FDA announced limits to packaging for anti- diarrhea medicine Loperamide (Imodium) to encourage safe use. FDA posted the revised Blueprint, “Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain,” which broadens the current Blueprint to include information on pain management, including the principles o
Ajouté au bande de temps:
Date:
30 janv. 2018
Maintenaint
~ Il y a 7 ans et 8 mois